Elravie Re2O ECM Skin Booster

Human Acellular Dermal Matrix (hADM) for Advanced Skin Quality & Structural Support

Elravie Re2O is an advanced ECM skin booster derived from human acellular dermal matrix (hADM) and manufactured using specialized processing and extraction technology. KFDA approved in South Korea, Re2O has gained significant attention in the Korean aesthetic market since 2025 as a new-generation approach to improving dermal structure and overall skin quality.

Unlike conventional treatments that focus primarily on hydration or immediate volume, Re2O introduces extracellular matrix components that are naturally associated with the structural environment of human skin.

Authentic Extracellular Matrix Components

Elravie Re2O provides a complex extracellular matrix composition containing:

Collagen – 89%
Elastin – 3%
GAGs / Hyaluronic Acid – 0.4%
Other ECM Components – 7.6%

Together, these components form a biological matrix designed to support the skin’s structural environment.

More Than Volume — Rebuilding the Skin Environment

Healthy skin depends on more than collagen alone.

The Extracellular Matrix (ECM) is the three-dimensional network surrounding cells within the dermis. It contains collagen, elastin, glycosaminoglycans (GAGs), and other structural components that influence skin strength, elasticity, hydration, and cellular behavior.

With aging, the quantity, organization, and quality of these components gradually decline. This contributes to visible changes such as:

Loss of firmness • Reduced elasticity • Fine lines • Thinner-looking skin • Rough texture • Enlarged-looking pores

Re2O takes a different approach by focusing on the dermal microenvironment rather than simply creating temporary surface volume.

1. Supports the Dermal Scaffold

Think of the extracellular matrix as the architectural framework of the skin.

Collagen provides strength and structural support, elastin contributes elasticity, while GAGs help maintain an appropriately hydrated extracellular environment.

By providing hADM-derived ECM components, Re2O is designed to support the structural environment of aging skin and contribute to a firmer, denser, and more resilient appearance.

2. Creates a Supportive Environment for Fibroblasts

Fibroblasts are essential cells responsible for producing and maintaining many components of the extracellular matrix, including collagen and elastin.

Cell behavior is strongly influenced by the surrounding ECM.

Rather than viewing anti-aging as simply “adding collagen,” Re2O focuses on providing an extracellular environment that can support cell adhesion, cell–matrix interaction, and tissue remodeling processes.

This creates a fundamentally different approach to conventional skin boosters.

3. Skin Density Instead of an Overfilled Look

Re2O is not positioned as a traditional volumizing dermal filler.

Conventional fillers can create volume by physically occupying space within the tissue. ECM-based treatment instead focuses on dermal quality and structural support.

The goal is progressive improvement in how the skin looks and feels—including firmness, smoothness, elasticity, and density—while maintaining natural facial contours.

No exaggerated volume. No overfilled appearance. Just better-looking skin quality.

4. A Complete Skin-Quality Approach

Because the extracellular matrix influences multiple characteristics of the dermis, Re2O can be incorporated into professional aesthetic protocols targeting several aspects of skin aging simultaneously.

Treatment may focus on improving the appearance of:

• Skin firmness
• Elasticity
• Fine lines
• Skin texture
• Enlarged pores
• Hydration
• Thin or lax-looking skin
• Overall skin density and resilience

This comprehensive approach is why ECM-based treatments have emerged as an interesting new category of skin quality boosters.

5. Human-Derived, Acellular ECM

Re2O is produced from human acellular dermal matrix (hADM).

During manufacturing, cellular components are removed while extracellular matrix components are retained and processed for the intended medical application.

The term “acellular” is important because Re2O is not a stem-cell treatment and does not mean that living human cells are being injected.

Instead, it utilizes processed human-derived extracellular matrix material.

Elravie Re2O Professional Treatment Protocol

Re2O is intended for administration by appropriately qualified healthcare professionals. The manufacturer’s official instructions for use should take precedence over any general treatment protocol.

Preparation

Reconstitute the 150 mg Re2O powder with 5 cc of sterile saline according to the recommended professional protocol.

For protocols focused on additional hydration and skin firmness, 2 cc of compatible non-crosslinked Hyaluronic Acid may be added to the 5 cc saline preparation.

Treatment Course

Treatment frequency should be one session in every 28 days, 3 to 5 sessions each treatment.

Elravie Re2O Post-Treatment Care

Immediately After Treatment

Temporary injection-site reactions may occur following treatment, including:

• Redness
• Mild swelling
• Tenderness
• Bruising
• Small raised areas at injection points

These reactions are generally temporary, but patients should contact their healthcare provider if symptoms are severe, unusual, or persistent.

Professional Post-Care Option

For additional soothing and hydration, a professional post-treatment skincare protocol may include the Luxevo Exobrant NMN Bio-Cellulose Post-Care Mask.

Where clinically appropriate, LED treatment may also be incorporated into the post-care protocol.

Any energy-based device treatment immediately following an injectable procedure should only be performed when considered appropriate by the treating professional.

At-Home Skin Care

For the days following treatment:

• Keep the skin adequately moisturized.
• Luxevo Exobrant Balm may be incorporated as a soothing post-care moisturizer.
• Apply broad-spectrum sunscreen daily.
• Minimize unnecessary direct sun exposure.
• Avoid aggressive exfoliating or irritating skincare products until the skin has recovered.

What to Avoid

Follow the treating professional’s instructions regarding exercise, heat exposure, alcohol, swimming, saunas, hot baths, massage, additional aesthetic procedures, and other activities following treatment.

Makeup and facial cleansing should only be resumed according to the clinician’s post-treatment instructions and once the injection sites are considered suitable.

Professional Use Only

Elravie Re2O is a human-derived medical/aesthetic product and should be handled, prepared, and administered only by appropriately qualified healthcare professionals.

Patient selection, contraindications, reconstitution, dosage, injection depth, treatment intervals, combination therapies, and post-treatment management should follow the official Elravie Re2O Instructions for Use (IFU) and applicable regulations in the country where treatment is performed.